arrow
S

Stefanie Hassel

University of Calgary
H指数:34
被引数:4,453

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 study

Lam就业缺勤和生产力量表(LEAPS):利用CAN-BIND-1研究数据对重度抑郁症患者最小临床重要差异(MCID)的分析

2026-02-170
OAAI
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics

与认知、不良生活事件、自伤行为、代谢组学和遗传学相关的大脑解剖学维度在重度抑郁症中的关联

2025-11-150
OAAI
Socioeconomic status is associated with reward processing, interleukin 1β, striatal connectivity and antidepressant outcomes in individuals with major depressive disorder: A CAN-BIND-1 report.

社会经济地位与奖励处理、白细胞介素1β、纹状体连接以及抗抑郁治疗效果在重度抑郁症个体中相关:一项CAN-BIND-1研究报告。

2025-10-310
OAAI
Standardized EEG for multi-site biomarker-informed trials: implementation in the Canadian biomarker integration network in depression

多中心生物标志物指导试验中的标准化EEG:在加拿大抑郁症生物标志物整合网络中的应用

2025-07-110
OAAI
Multi-Voxel pattern analysis for characterizing functional connectivity and neurocognitive function in major Depression: A CAN-BIND-1 Report

多体素模式分析用于表征重度抑郁症的功能连接和神经认知功能:一份CAN-BIND-1报告

2025-07-100
OAAI
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study

预测维持治疗期间抑郁发作的复发:加拿大抑郁生物标志物整合网络(CAN-BIND)重度抑郁症健康监测研究

2025-04-290
PRE
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1
2025-03-010
PRE
Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume
2024-10-120
OAAI
Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive Disorder
2024-08-010
PRE
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study

艾司西酞普兰和阿立哌唑治疗抑郁症的综合遗传变异,DNA甲基化和基因表达分析: 一项CAN-BIND-1研究

2024-06-250
PRE
An empirical analysis of structural neuroimaging profiles in a staging model of depression
2024-04-011
PRE
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report
2024-01-012
PRE
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

CYP2C19,CYP2D6和ABCB1基因变异以及依他普仑和阿立哌唑的血清水平对治疗中出现的性功能障碍的影响: 加拿大抑郁症生物标志物整合网络1 (CAN-BIND 1) 研究

2023-10-053
OAAI
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
2023-09-152
OAAI
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study
2023-03-067
OAAI
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
2023-01-2310
OAAI
Gray matter volume drives the brain age gap in schizophrenia: a SHAP study
2023-01-0919
OAAI